IN8BIO, INC. — Investor Relations & Filings
IN8BIO, INC. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell therapies for solid and hematological tumors. The company's proprietary DeltEx™ platform utilizes allogeneic, autologous, and genetically modified approaches to develop novel cell therapies. IN8BIO was the first to advance genetically modified gamma-delta T cells into clinical trials. Its lead product candidates include INB-400, a Phase 2 asset for newly diagnosed glioblastoma (GBM), and INB-100, a Phase 1 candidate for patients with leukemia undergoing hematopoietic stem cell transplantation. The company is also advancing a broad portfolio of preclinical programs focused on solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3/A | 2026-05-18 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46474546 | S-3/A | 2026-05-18 | English | ||
| 43589305 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589284 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589220 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589208 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589206 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43596317 | S-8 - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43518284 | 8-K - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 33052209 | ARS - IN8BIO, INC. (0001740279) (Filer) | 2026-03-26 | English | ||
| 32897569 | 8-K - IN8BIO, INC. (0001740279) (Filer) | 2026-02-27 | English | ||
| 31546757 | 8-K Filing | 2026-02-09 | English | ||
| 31546837 | 4 Filing | 2026-02-06 | English | ||
| 31546738 | 4 Filing | 2026-02-06 | English | ||
| 31546677 | 4 Filing | 2026-02-06 | English | ||
| 31546594 | 4 Filing | 2026-02-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
IN8BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35200/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35200 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35200 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35200 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35200}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IN8BIO, INC. (id: 35200)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.